The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM) Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Age is a major risk factor of venous thromboembolism (VTE) Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
The acquired and inherited risk factors in venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020 Year: 2020
The role of thrombophilic risk factors in the severity of pulmonary thromboembolism Source: Eur Respir J 2002; 19: 709-711 Year: 2002
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis Source: Eur Respir J 2003; 21: 25-30 Year: 2003
Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE) Source: Eur Respir J 2005; 26: Suppl. 49, 521s Year: 2005
Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)? Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006
Venous thromboembolic (VTE) in patients with ALS: an incidence study Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021
Risk factors in patients with venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Inherited thrombophilic risk factors in venous thromboembolism Source: Eur Respir J 2002; 20: Suppl. 38, 239s Year: 2002
Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004
Over reliance on D-dimer requests in the diagnosis of venous thromboembolism (VTE) Source: Eur Respir J 2003; 22: Suppl. 45, 220s Year: 2003
Genetic and acquired risk factors of venous thromboembolism Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=1 Year: 2004
D-dimer in patients with venous thromboembolism who carry hereditary thrombophilia Source: Eur Respir J 2006; 28: Suppl. 50, 46s Year: 2006
PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012
Factors affecting recurrence and bleeding complications in patients withvenous thromboembolism Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001